Enveric Biosciences (ENVB) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Climate Environment Environmental Environmental Protection Green Hazard Intensity Leach Materials Nature Offset Package Packaging Pandemic Pollution Raw Materials Access Benefits Black Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Security Death Disability Diversity Drug Pricing Employee Engagement Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Resources Incident Injury Opioid Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Violence Volunteer Workers Activist Assessment Assurance Attorneys General Audit Bonus Chronic Classified Clawback Commitment Conflict of Interest Controversy Corporate Governance Corporate Purpose Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Oversee Oversight Plaintiff Pledging Procurement Proxy Contest Purpose R&D Recoup Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Special Meeting Strategy Sustainable Targets Tax Tenure Term Limit Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On October 28, 2022, Enveric Biosciences, Inc. (the “Company”) held its 2022 annual meeting of stockholders (the “Annual Meeting”). A total of 856,447 shares of the Company’s common stock were present in person or represented by proxy at the Annual Meeting, which represented 41.2% of the outstanding shares of common stock entitled to vote at the Annual Meeting and constituted a quorum for the transaction of business. Holders of the Company’s common stock were entitled to one vote per share of common stock held as of the close of business on September 14, 2022, the record date for the Annual Meeting. The matters submitted for a vote and the related results are set forth below.

Election of seven directors, to serve until the Company’s 2023 annual meeting of stockholders or until their successors are duly elected and qualified.

Nominee
George Kegler	138,269	109,803	608,375
Douglas Lind, M.D.	228,007	20,065	608,375
Bevin O’Neil	226,712	21,360	608,375
Frank Pasqualone	226,764	21,308	608,375
Marcus Schabacker, M.D., Ph.D.	139,581	108,491	608,375
Joseph Tucker, Ph.D.	228,825	19,247	608,375
Michael D. Webb	226,729	21,343	608,375

Non-binding advisory vote to approve the compensation of the Company’s named executive officers.

For			Against				Abstain				Broker Non-Votes
178,176				68,125				1,771				608,375

Ratification of the selection and appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022

For			Against				Abstain
826,728				27,656				2,063

For more information about the foregoing proposals, see the Company’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on September 23, 2022, the relevant portions of which are incorporated herein by reference. The results reported above are final voting results. No other matters were considered or voted upon at the meeting.